UCB raises 2012 revenue target

Following strong sales of its three core products, UCB SA has upgraded its revenue forecast for 2012 and now expects sales will be in excess of €3.2 billion, aligning it more closely with 2011 when revenue was €3,246 million. UCB had been anticipating revenue of around €3.1 billion.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium